Acetazolamide Tablet
Product Images NDC 70954-034

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 70954-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Acetazolamide-structure (Acetazolamide Structure)

Acetazolamide-structure (Acetazolamide Structure)
Chemical structure diagram of acetazolamide, showing the arrangement of its atoms and bonds. The structure includes a sulfonamide group and heterocyclic rings characteristic of acetazolamide.*
FDA Label Image

Container1 (Container1)

Container1 (Container1)
Acetazolamide 125 mg Tablets, USP, packaged as 100 tablets in a container labeled by Novitium Pharma. The label includes storage instructions, a barcode, manufacturer details, and a note that the package is not for household dispensing. The label indicates Rx only status and advises use of a safety seal under the cap.*
FDA Label Image

Container2 (Container2)

Container2 (Container2)
Label for Acetazolamide tablets, USP, 250 mg strength, showing a bottle count of 100 tablets. The label includes storage instructions, safety warnings, and the manufacturer listed as Novitium Pharma LLC. The design features the product name prominently with dosage strength in a green box and a barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.